Sepsis-induced cardiomyopathy: What is it and what do we do about it?
Try out using Rapid Sequence for groups, in conference, or as an asynchronous learning activity: rapidsequence.org/for-educators
References:
Jentzer et al. Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients. Circ Cardiovasc Qual Outcomes. 2020;13(12):e006956
Chavez et al. Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circ Heart Fail. 2024;17(9):e011827
Shapiro et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. NEJM 2023;388(6):499-510
Sato et al. Effects of Inotropes on the Mortality in Patients With Septic Shock. J Intensive Care Med 202;36(2):211-219
Tarbaghia et al. Dobutamine in septic shock, when and why? Am J Respir Crit Care Med 2025;211:A3748
Sato et al. Sepsis-induced cardiomyopathy: Mechanism, Prevalence, Assessment, Prognosis, and Management. Chest 2025; 3:S0012-3692(25)05143-8
Vallabhajosyula et al. Impact of Right Ventricular Dysfunction on Short-term and Long-term Mortality in Sepsis. Chest 2021;159(6):2254-2263
D'autres épisodes de "ICUedu"



Ne ratez aucun épisode de “ICUedu” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








